In this episode of Moving Medicine Forward, we are joined by Courtney Cordaro, Director and Therapeutic Strategy & Innovation Lead at CTI, for an in-depth conversation about the evolving world of hematology clinical research. From navigating rare disease trials to embracing decentralized strategies and cutting-edge therapies like cell and genetreatments, Courtney shares her expertise on operational excellence, patient engagement, and the trends shaping the future of hematology studies. Whether you’re a sponsor, researcher, or simply curious about medical innovation, this episode offers actionable insights and a look at what’s next in clinical research.

01:00 Courtney’s Background: From human nutrition to clinical research—how Courtney found her passion in advancing treatments for hematologic conditions.

02:29 Why Hematology?: The urgent need, complexity, and rapid innovation in hematology trials.

03:57 Unique Challenges: Small patient populations, nuanced endpoints, intensive protocols, and regulatory scrutiny.

05:17 Evolving Role of Project Management: Impact of decentralized trials, advanced therapies, and technology on trial operations.

08:28 Maintaining Compliance & Data Integrity: Strategies for site engagement, risk mitigation, and cross-functional collaboration.

10:46 CTI’s Differentiators: Tailored approaches, patient centric strategies, and operational agility in hematology research.

13:54 Future Trends: Cell and gene therapies, precision medicine, and innovations shaping hematology trials.

15:19 Five Pillars of Success: Planning, site/patient engagement, operational excellence, data oversight, and collaboration.

18:01 Advice for Sponsors: Key considerations for entering the hematology space for the first time.